Personalized precision medicine powered by AI for cancer therapy
Stage
MVP
Not given
Founded
Not given
Not given
Based in
Not given
US
Pricing model
Contact for pricing
Contact for pricing
Pricing
Two subscription tiers planned: Basic (core readiness, training, recovery, and trend experience) and Pro (deeper testing and interpretation). Early Access members will receive 3 months of COR5 Pro at no additional cost with device purchase. Final pricing to be confirmed before reservations open.
Not given
Key features
ECG and pulse wave synchronization for cardiac and vascular response measurement
Multi-frequency bioimpedance for body composition and hydration tracking
Personal physiological baseline built over approximately 10 days of consistent testing
Training ARC: before, during, and after training measurements
Performance Lab for custom longitudinal analysis and squad-level comparison
Coach dashboard with squad-wide readiness and individual athlete profiles
Snapshot test for quick 90-second current state check
Body Response test measuring seated-to-standing autonomic function
Balance Check for coordination and postural stability assessment
Onboard data capture without active network connection
Analyzes digital pathology with no additional tissue staining required
Rapid results within 1-2 days after specimen receipt
Validated across diverse populations including African American and non-African American men
FDA De Novo authorization for prostate cancer risk stratification
Insurance coverage for Medicare and many commercial plans
Provides 5 and 10-year distant metastasis risk for breast cancer
Identifies breast cancer patients who benefit from chemotherapy
Included in NCCN Clinical Practice Guidelines for Prostate Cancer
What makes it different
Personal baseline comparison instead of population averages
Five synchronized sensor modalities in one measurement experience
Active testing during training (before, during, after) rather than passive monitoring only
Field Sports Mode for phone-free pitch monitoring via LoRaWAN
Physiological signature that becomes more personalized with each new test
No additional tissue preparation needed, uses existing H&E slides
Validated across multiple large randomized phase III clinical trials
FDA De Novo clearance as Software as a Medical Device
Financial assistance program to make tests affordable regardless of income
ArteraAI